Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial (Q84580086)
Jump to navigation
Jump to search
scientific article published on 01 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial |
scientific article published on 01 August 2012 |
Statements
Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial (English)
M Hakala
H Kröger
H Valleala
T Hienonen-Kempas
M Lehtonen-Veromaa
J Heikkinen
T Tuomiranta
P Hannonen
L Paimela
ONCE trial group
1 August 2012